Hemostemix Clarifies its October 3, 2023 News Release
Newsfile Corp. December 30, 2023 In this article: Calgary, Alberta–(Newsfile Corp. – December 29, 2023) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to like to clarify its press release of October 3, 2023. It refered to the private placement of $320,125. The Company closed the financing in the […]
Hemostemix’s 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease
Newsfile Corp. October 30, 2023 In this article: Calgary, Alberta–(Newsfile Corp. – October 30, 2023) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that Stem Cell Research & Therapy published the Company’s seventh peer reviewed study of ACP-01 – the third peer reviewed study of ACP-01 as a treatment for heart disease […]